Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Respirology · 2025-10 · 30 (10) · 957-969
DOI: 10.1111/resp.70071 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Respirology, 2025-07. Verfasst von Joong-Yub Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul National University Coll…. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Environmental Industry and Technology Institute, Korea National Institute of Health, National Research Foundation of Korea.
Abstract (Originalsprache)
Background and Objectives Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) is a frequent and fatal complication of IPF, with highly variable individual outcomes that are challenging to predict.
Methods
This study included patients (≥ 19 years) who met the diagnostic criteria for AE‐IPF. The primary outcome was 30‐day mortality following hospital admission. Data on commonly assessed parameters at the time of emergency room presentation or hospital admission were collected. Variable selection and scoring were performed using the LASSO method and multivariable logistic regression, and the resulting model was validated in an independent cohort.
Results
The derivation and validation cohorts comprised 128 and 100 patients, respectively. The final model incorporated eight variables (points): age ≥ 69 years (1), smoking status (current smoker: 2, past smoker: 1), use of home oxygen (1), history of hospital admission for non‐AE events within the past 6 months (1), body mass index < 18.5 or > 23 kg/m 2 (1), lymphocyte percentage < 19% (2), total protein < 6.5 g/dL (1) and lactate level ≥ 1.75 mmol/L (1). Patient scores were calculated by summing the points for each variable. This scoring system of total 10 points demonstrated good discrimination, with Harrell's C‐statistics of 0.84 (95% confidence interval, 0.75–0.93) in the derivation cohort and 0.81 (95% confidence interval, 0.71–0.92) in the validation cohort, and performed well in predicting 2‐week, 3‐month and in‐hospital mortality.
Conclusion
We developed and validated a scoring system based on readily available clinical parameters that effectively stratified 30‐day mortality risk in patients with AE‐IPF, offering a practical tool for bedside prognosis. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Medical Research Collaborating Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mokdong Hospital, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
- Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Critical Care Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
- Division of Pulmonary and Allergy Medicine, Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Joong-Yub Kim, Min Jee Kim, Nakwon Kwak, Jaeyoung Cho, Jinwoo Lee, Chang-Hoon Lee, Sang-Min Lee, Jin Woo Song, Sun Mi Choi
Förderung
- Korea Environmental Industry and Technology Institute
- Korea National Institute of Health
- National Research Foundation of Korea
Zitieren
APA
Kim, J. Y., Kim, J., Choi, M. G., Kim, M. J., Ahn, Y. H., Kwak, N., Cho, J., Lee, J., Park, Y. S., Lee, C. H., Lee, S. M., Yoo, C. G., Song, J. W., & Choi, S. M. (2025). Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Respirology, 30(10), 957-969. https://doi.org/10.1111/resp.70071
Vancouver
Kim JY, Kim J, Choi MG, Kim MJ, Ahn YH, Kwak N, et al. Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis. Respirology. 2025;30(10):957-969. doi:10.1111/resp.70071
BibTeX
@article{Kim2025,
author = {Kim, Joong-Yub and Kim, Jayoun and Choi, Myeong Geun and Kim, Min Jee and Ahn, Yun Hae and Kwak, Nakwon and Cho, Jaeyoung and Lee, Jinwoo and Park, Young Sik and Lee, Chang-Hoon and Lee, Sang-Min and Yoo, Chul-Gyu and Song, Jin Woo and Choi, Sun Mi},
title = {Development and Validation of a Clinical Scoring System Predicting 30‐Day Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis},
journal = {Respirology},
year = {2025},
volume = {30},
number = {10},
pages = {957--969},
doi = {10.1111/resp.70071}
}
EUVIMED